Amphastar Pharma (AMPH) Reports Q1 Loss of 1c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. LITE
5. CL
6. TFII
7. LYB
8. NVT
9. SPY
10. AAPL

Go back to Amphastar Pharma (AMPH) Reports Q1 Loss of 1c/Share

Jefferies Remains Bullish Following Amphastar Pharma's (AMPH) Strong Q1

May 14, 2015 10:27 AM EDT

Jefferies maintains a Buy rating on Amphastar Pharmaceuticals (NASDAQ: AMPH), and raised the price target to $19.00 (from $18.00), after a strong Q1. Analyst David Steinberg said that the strong Q1 was driven by a better than expected top line.

Steinberg commented on AMPH, saying, "Posting sales of $27.1M (+37% Y/Y), AMPHs base IMS injectables business contributed to half of the Q1 rev upside relative to our est, largely reflecting price... More